7Baggers

Sundial Growers Inc
(NASDAQ:SNDL) 

SNDL stock logo

Sundial Growers Inc. engages in production and marketing of cannabis products for the adult-use market in Canada. It produces and distributes inhalable products, such as flower, pre-rolls, and vapes. The company offers its products under the Top Leaf, Sundial Cannabis, Palmetto, and Grasslands brand...

Founded: 2006
IPO Price: $13 (Aug 01, 2019)
Full Time Employees: 868
Founder: Stan Swiatek 
CEO: Torsten Kuenzlen  
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
CannabisCanadian
Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
    Unit: USD2025-11-04 2025-11-03 2025-07-31 2025-07-30 2025-05-01 2025-04-30 2025-03-18 2024-11-05 2024-11-04 2024-08-01 2024-05-09 2024-05-08 2024-03-21 2023-11-13 2023-08-14 2023-08-11 2023-03-31 2022-12-31 2022-11-14 2022-09-19 2022-08-12 2022-06-14 2022-05-15 2021-12-31 2021-11-11 2021-08-12 2021-05-11 2020-12-31 2020-11-11 2020-10-13 2020-08-13 2020-05-15 2019-12-31 2019-11-13 2019-09-30 2019-06-30 
                                        
      net revenue
    		244,219,000 244,219,000 244,769,000 244,769,000 204,914,000 204,914,000 920,448,000 236,892,000 236,892,000 228,127,000 197,750,000 197,750,000 909,006,000 237,595,000 244,511,000 244,511,000 202,452,000 240,405,000 230,500,000  223,695,000  17,597,000 22,719,000 14,367,000 9,151,000 9,891,000 13,853,000 12,865,000 63,562,000 20,194,000 23,037,000 75,805,690 33,512 33,512,000  
      cost of sales
    		180,042,000 180,042,000 177,168,000 177,168,000 148,273,000 148,273,000 680,117,000 173,924,000 173,924,000 169,963,000 147,350,000 147,350,000 689,338,000 180,375,000 188,922,000 188,922,000 158,149,000 190,379,000 179,093,000  174,291,000  14,326,000 15,918,000 11,704,000 9,534,000 11,445,000 10,638,000 10,259,000 46,721,000 17,336,000 20,489,000   24,822,000  
      gross profit
    		64,177,000 64,177,000 67,601,000 67,601,000 56,641,000 56,641,000 240,331,000 62,968,000 62,968,000 58,164,000 50,400,000 50,400,000 190,415,000                        
      yoy
    		13.30% 13.30% -71.87% 7.36% -10.05% -2.62% 376.85% 24.94% -66.93%                            
      qoq
    		0.00% -5.07% 0.00% 19.35% 0.00% -76.43% 281.67% 0.00% 8.26% 15.40% 0.00% -73.53%                         
      investment income
    		1,777,000 1,777,000 1,529,000 1,529,000 2,856,000 2,856,000 15,551,000 5,577,000 5,577,000 3,204,000 4,036,000 4,036,000      -14,574,000 -5,513,000  -35,073,000  -17,710,000              
      share of profit of equity-accounted investees
    		-234,000 -234,000 304,000 304,000 -4,457,000 -4,457,000 -65,459,000 -13,401,000 -13,401,000 5,252,000 9,148,000 9,148,000 6,758,000 6,581,000 -936,000 -936,000 9,516,000 -18,291,000 9,176,000  -37,978,000  4,091,000 19,271,000 9,918,000 3,724,000           
      general and administrative
    		45,967,000 45,967,000 45,376,000 45,376,000 46,359,000 46,359,000 187,243,000 49,980,000 49,980,000 48,036,000 44,695,000 44,695,000 199,725,000 48,235,000 52,727,000 52,727,000 48,573,000 44,179,000 45,014,000  40,293,000  10,682,000 11,639,000 9,552,000 10,086,000 7,093,000 6,528,000 7,158,000 38,934,000 7,735,000 14,393,000   14,577,000  
      sales and marketing
    		3,617,000 3,617,000 3,384,000 3,384,000 3,767,000 3,767,000 12,004,000 2,813,000 2,813,000 3,439,000 2,598,000 2,598,000 15,045,000 3,271,000 4,104,000 4,104,000 3,386,000 2,239,000 1,935,000  3,132,000  1,111,000 1,501,000 1,277,000 1,315,000 950,000 2,310,000 1,117,000 8,068,000 518,000 2,280,000   2,467,000  
      depreciation and amortization
    		12,928,000 12,928,000 12,920,000 12,920,000 13,228,000 13,228,000 54,250,000 13,389,000 13,389,000 13,519,000 14,143,000 14,143,000 60,216,000 15,545,000 13,443,000 13,443,000 16,468,000 21,623,000 9,783,000  8,800,000  739,000 352,000 2,385,000 931,000 1,058,000 1,297,000 1,480,000 595,000 1,277,000 2,247,000   1,278,000  
      share-based compensation
    		10,883,000 10,883,000 2,919,000 2,919,000 1,388,000 1,388,000 20,037,000 5,702,000 5,702,000 4,883,000 4,843,000 4,843,000 15,400,000 5,373,000 3,893,000 3,893,000 2,209,000 2,960,000 2,069,000  438,000  4,204,000 2,443,000 1,869,000 4,539,000 3,456,000 1,501,000 3,118,000 38,698,000 1,885,000 1,236,000   8,398,000  
      restructuring costs
    		1,134,000 1,134,000 827,000 827,000 326,000 326,000 2,667,000  1,918,000    19,573,000 708,000 4,042,000 4,042,000 1,536,000 212,000   -882,000       280,000 1,108,000  2,363,000 2,719,000     
      asset impairment (recovery)
    		2,051,000 2,051,000                                   
      research and development
    		156,000 156,000 98,000 98,000 100,000 100,000 346,000 76,000 76,000 109,000 37,000 37,000 324,000 57,000 20,000 20,000 140,000 460,000 1,503,000  390,000  95,000 739,000 714,000 758,000 235,000 110,000 35,000  36,000 307,000     
      gain on disposition of assets
    		34,000 34,000            -14,000 -77,000 -77,000 -184,000                    
      operating income
    		-11,050,000 -11,050,000 5,003,000 5,003,000 -12,053,000 -12,053,000 -103,811,000 -18,511,000 -18,511,000 -4,834,000 -4,377,000 -4,377,000 -162,818,000                        
      yoy
    		-8.32% -8.32% -104.82% -127.03% -34.89% 149.34% 2271.74% 322.92% -88.63%                            
      qoq
    		0.00% -320.87% 0.00% -141.51% 0.00% -88.39% 460.81% 0.00% 282.93% 10.44% 0.00% -97.31%                         
      other (expenses) income
    		-2,269,000 -2,269,000                                   
      income before income tax
    		-13,319,000 -13,319,000   -14,707,000 -14,707,000 -105,609,000 -17,902,000 -17,902,000 -6,251,000 -7,649,000 -7,649,000 -172,016,000  -29,988,000   -54,893,750 -105,771,000  -75,764,000  -38,040,000 -46,974,000 1,253,000       -44,213,000     
      income tax (expense) recovery
    		        -1,434,000                            
      net income
    		-13,319,000 -13,319,000   -14,707,000 -14,707,000 -96,204,000 -19,336,000 -19,336,000 -4,967,000 -4,652,000 -4,652,000 -176,551,000 -21,827,000 -33,158,000 -33,158,000 -36,143,000 -161,571,000 -98,844,000  -73,973,000  -38,040,000 -54,761,000 11,311,000 -52,287,000 -134,445,000 -64,144,000 -71,397,000 -271,629,000 -60,420,000 -43,983,000 -271,502,457 -97,491 -97,491,000  
      yoy
    		-9.44% -9.44%   -23.94% 196.09% 1968.01% 315.65% -89.05% -77.24% -85.97% -85.97% 388.48% -86.49% -66.45%  -51.14%  159.84%  -753.99%  -71.71% -14.63% -115.84% -80.75% 122.52% 45.84% -73.70% 278519.56% -38.03%      
      qoq
    		0.00%    0.00% -84.71% 397.54% 0.00% 289.29% 6.77% 0.00% -97.37% 708.87% -34.17% 0.00% -8.26% -77.63% 63.46%     -30.53% -584.14% -121.63% -61.11% 109.60% -10.16% -73.72% 349.57% 37.37% -83.80% 278389.77% -99.90%   
      equity-accounted investees - share of other comprehensive income
    		7,709,000 7,709,000 -20,611,000 -20,611,000 -348,000 -348,000 31,489,000 -4,802,000 -4,802,000 4,300,000 10,034,000 10,034,000 -12,771,000 11,124,000 -11,621,000 -11,621,000                     
      investments at fair value through other comprehensive income ("fvoci") - change in fair value
    		12,940,000 12,940,000  2,044,000  -5,230,000                               
      comprehensive income
    		7,330,000 7,330,000 -15,682,000 -15,682,000 -20,285,000 -20,285,000  -24,138,000  -667,000 5,382,000 5,382,000      -45,417,250 -75,650,000     -43,855,250 11,311,000            
      net income attributable to:
    		                                    
      owners of the company
    		-13,319,000 -13,319,000 2,885,000 2,885,000 -14,707,000 -14,707,000 -94,796,000 -19,328,000 -19,328,000 -5,772,000 -2,554,000 -2,554,000 -168,125,000 -21,784,000 -29,350,000 -29,350,000 -34,203,000 -125,801,000 -98,108,000  -73,301,000                
      non-controlling interest
    		      -1,408,000  -8,000 805,000 -2,098,000 -2,098,000 -3,891,000 -43,000 -638,000 -638,000 -575,000 -35,770,000 -736,000  -672,000  -136,000 229,000   -29,000 -85,000 -11,000 -165,000 -77,000 -88,000   4,812,000 4,851,000 
      comprehensive income attributable to:
    		                                    
      net income per common share attributable to owners of the company
    		                                    
      basic and diluted
    		-50 -50    -60   -70   -10         -310  -20         -410     
      asset (recovery) impairment
    		  -1,064,000 -1,064,000                                 
      (gain) loss on disposition of assets
    		  -29,000 -29,000 -59,000 -59,000                               
      other incomes
    		  -2,118,000 -2,118,000 -2,654,000 -2,654,000 -1,798,000                              
      earnings before income tax
    		  2,885,000 2,885,000                                 
      income tax recovery
    		      9,405,000 -1,434,000  1,284,000 2,997,000 2,997,000      -1,376,000 6,927,000  1,791,000   -7,787,000 10,058,000     3,609,000  230,000   512,000  
      net earnings
    		  2,885,000 2,885,000                                 
      investments at fair value through other comprehensive income (fvoci) - change in fair value
    		  2,044,000                                  
      net earnings attributable to:
    		                                    
      net earnings per common share attributable to owners of the company
    		                                    
      basic and diluted
    		   10                                 
      asset impairment
    		    1,984,000 1,984,000 17,317,000 -258,000 -258,000 919,000 1,656,000 1,656,000 54,967,000 1,783,000 1,658,000 1,658,000 807,000 107,661,000 86,522,000  1,850,000     60,000,000  13,532,000 60,000,000 162,000  5,659,000     
      investments at fvoci - change in fair value
    		    -5,230,000  1,864,000                              
      loss on disposition of assets
    		      370,000 35,000 35,000 328,000 78,000 78,000 -353,000                        
      net income from continuing operations
    		      -96,204,000 -19,336,000 -19,336,000 -4,967,000 -4,652,000 -4,652,000 -172,016,000 -21,827,000 -29,988,000 -29,988,000 -34,778,000       -54,761,000 11,311,000 -52,287,000 -134,445,000 -64,144,000 -71,397,000 -142,698,000 -31,560,000      
      net income from discontinued operations
    		            -4,535,000  -3,170,000                      
      comprehensive loss
    		      -62,851,000  -24,138,000    -189,322,000 -10,703,000 -44,784,000 -44,784,000 -36,523,000    -61,246,000  -44,773,000   -52,287,000 -134,445,000 -64,144,000 -71,397,000 -264,763,000 -61,513,000 -42,290,000   -101,360,000  
      net income from continuing operations attributable to:
    		                                    
      comprehensive loss attributable to:
    		                                    
      restructuring (recovery) costs
    		       1,918,000  221,000 -89,000 -89,000                         
      other income
    		       609,000 609,000 -1,417,000 -3,272,000 -3,272,000                         
      gain on translation of foreign operations
    		               -5,000 5,000              -1,093,000      
      gross revenue
    		            957,725,000 249,796,000 257,425,000 257,425,000 212,899,000 246,866,000 235,144,000  227,557,000  20,127,000 25,630,000 17,162,000 12,739,000 11,748,000 16,865,000 15,525,000 66,927,000 24,341,000 25,621,000 79,168,844 34,181 34,181,000  
      excise taxes
    		            48,719,000 12,201,000 12,914,000 12,914,000 10,447,000 6,461,000 4,644,000  3,862,000  2,530,000 2,911,000 2,795,000 3,588,000 1,857,000 3,012,000 2,660,000 3,365,000 4,147,000 2,584,000   669,000  
      inventory impairment and obsolescence
    		            30,644,000 9,126,000 4,291,000 4,291,000 9,177,000    3,871,000                
      gross profit before fair value adjustments
    		            189,024,000                        
      change in fair value of biological assets
    		            -7,936,000 -1,819,000 -1,413,000 -1,413,000 -3,535,000 -2,712,000 -1,899,000  -388,000  3,690,000 2,158,000 2,975,000 -331,000 -94,000 579,000 194,000 30,340,000 -1,756,000 7,083,000   11,856,000  
      change in fair value realized through inventory
    		            9,327,000 2,330,000 2,048,000 2,048,000 950,000 -279,000 -1,506,000  -2,066,000  -1,561,000 -1,756,000 15,000 -456,000 -50,000 -214,000 -2,447,000  -6,213,000 -9,692,000   -5,875,000  
      interest and fee revenue
    		            14,517,000 3,445,000 3,421,000 3,421,000 4,211,000 5,989,000 4,312,000  2,577,000  3,861,000 3,647,000 3,309,000 3,344,000 2,849,000          
      investment loss
    		            -9,258,000 -29,000 -4,020,000 -4,020,000 -5,169,000       -41,755,000 -18,008,000            
      gain on cancellation of contracts
    		                                    
      transaction costs
    		            -3,718,000 -226,000 -173,000 -173,000 -2,040,000 -2,392,000 -417,000  7,938,000  -6,481,000 -7,837,000 -5,276,000 -805,000 -3,648,000 -825,000 -364,000 -8,481,000 -1,297,000 -1,101,000   -7,751,000  
      finance costs
    		            -11,362,000 -2,142,000 -2,458,000 -2,458,000 -5,173,000       -3,530,000 -135,000 -40,000 -51,000   -24,216,000 -591,000 -6,174,000   -12,558,000  
      change in estimate of fair value of derivative warrants
    		            6,602,000 -2,840,000 2,240,000 2,240,000 4,802,000 3,927,000 -8,500,000  23,656,000  -8,300,000 8,200,000 24,100,000 19,810,000 -129,944,000          
      foreign exchange loss
    		            -367,000          -150,000     204,000 -249,000 939,000 599,000    190,000  
      gross margin before fair value adjustments
    		             48,094,000 51,298,000 51,298,000 35,126,000 46,559,000 53,714,000  45,533,000  1,290,000 -2,901,000 -1,208,000 -2,034,000 -3,308,000 -5,060,000 -17,291,000 16,841,000 -7,168,000 -5,167,000 19,694,724 8,690 8,690,000  
      gross margin
    		             48,605,000 51,933,000 51,933,000 32,541,000 43,568,000 50,309,000  43,079,000  3,419,000 -2,499,000 1,782,000 -2,821,000 -3,452,000 -4,695,000 -19,544,000 36,496,000 -15,137,000 -7,776,000   14,671,000  
      income from operations
    		             -16,370,000 -29,489,000 -29,489,000 -32,020,000 -154,646,000 -88,542,000  -81,416,000  -23,170,000 -44,000,000 -18,796,000 -71,020,000 1,685,000 -33,881,000 -89,230,000 -53,310,000 -29,550,000 -36,787,000 -159,186,757 -12,435 -12,435,000  
      foreign exchange gain
    		             -235,000 -31,000 -31,000 -163,000 -121,000 91,000  161,000   -181,000 1,360,000 -208,000 -440,000     170,000     
      loss before income tax
    		             -21,827,000  -29,988,000 -34,778,000         -52,287,000 -134,445,000 -35,543,250 -71,397,000 -146,307,000 -31,560,000      
      net loss from discontinued operations
    		               -3,170,000 -1,365,000           -8,406,750  -128,931,000 -28,860,000      
      net loss from continuing operations attributable to:
    		                                    
      net loss attributable to:
    		                                    
      net loss per common share attributable to owners of the company
    		                                    
      basic and diluted
    		             -80  -120 -140         -30 -90 -377.5 -530 -3,170 -570    -1,060  
      note
    		                                    
      balance at december 31, 2022
    		                                    
      other comprehensive loss
    		                                    
      share repurchases
    		                                    
      share issuances by subsidiaries
    		                                    
      acquisition
    		                                    
      shares acquired and cancelled
    		                                    
      employee awards exercised
    		                                    
      distribution declared by subsidiaries
    		                                    
      balance at september 30, 2023
    		                                    
      balance at june 30, 2023
    		                                    
      other comprehensive income
    		                                    
      balance at march 31, 2023
    		                                    
      equity-accounted investees - share of other comprehensive loss
    		                -385,000                    
      balance at december 31, 2021
    		                                    
      share issuances
    		                             8,123,000       
      balance at march 31, 2022
    		                                    
      inventory impairment (recovery) and obsolescence
    		                 886,250 -2,307,000                  
      government subsidies
    		                          -2,180,000 -47,000 -4,081,000        
      finance income (costs)
    		                 -8,713,250 -8,409,000  -26,505,000  61,000              
      gain on disposition of pp&e
    		                 102,000 6,000  402,000   374,000  -22,000 -117,000   8,000 -122,000 610,000   -6,000  
      equity-accounted investees - share of oci, net of tax
    		                 7,297,000 23,194,000                  
      net income per common share attributable to owners of the company
    		                                    
      basic
    		                 -230 -410     -25 6            
      diluted
    		                 -230 -410     -25 5            
      inventory
    		                   9,523,000  9,523,000            28,420 28,420,000 17,485,000 
      other current assets
    		                   486,000  486,000               
      property and equipment
    		                   5,750,000  5,750,000               
      right-of-use assets
    		                   2,691,000  2,691,000               
      intangible assets
    		                   17,509,000  17,509,000             44,096,000 18,663,000 
      total assets
    		                   35,959,000  35,959,000            632,057 632,057,000 369,217,000 
      lease liabilities
    		                   12,384,000  12,384,000               
      total liabilities
    		                   12,384,000  12,384,000             296,241,000 345,741,000 
      total net assets
    		                   23,575,000  23,575,000               
      sales
    		                                    
      selling and distribution expenses
    		                                    
      administrative expenses
    		                                    
      operating profit before depreciation, remeasurements and other costs
    		                                    
      impairment, lease remeasurements and other costs
    		                                    
      operating profit
    		                                    
      gain on sale before income tax and other adjustments
    		                                    
      gain on realized foreign exchange
    		                                    
      profit before income taxes
    		                                    
      income tax expense
    		                   15,000  15,000               
      net earnings from discontinued operations
    		                                    
      based earnings per share from discontinued operations
    		                   20  20               
      diluted earnings per share from discontinued operations
    		                   20  20               
      equity-accounted investees - share of oci
    		                    12,727,000  -6,733,000              
      inventory obsolescence
    		                      1,981,000 9,702,000 3,871,000 1,651,000 1,754,000 8,275,000 19,897,000  10,026,000      
      loss on disposition of pp&e
    		                                    
      sundial growers inc.
    		                      -37,904,000 -54,990,000 11,311,000 -52,287,000 -134,416,000 -64,059,000 -71,386,000 -142,533,000 -31,483,000 -43,895,000   -97,452,000  
      net income per common share attributable to sundial growers inc.
    		                                    
      basic and diluted
    		-50 -50    -60   -70   -10         -310  -20         -410     
      net income per common share attributable to sundial growers inc.
    		                                    
      basic
    		                 -230 -410     -25 6            
      diluted
    		                 -230 -410     -25 5            
      investment revenue
    		                         2,362,000 12,900,000          
      other expenses
    		                         -2,000 -1,930,000          
      net loss per common share attributable to sundial growers inc.
    		                                    
      basic and diluted
    		             -80  -120 -140         -30 -90 -377.5 -530 -3,170 -570    -1,060  
      balance at december 31, 2020
    		                                    
      loss of control of subsidiary
    		                                    
      share issuance costs
    		                             -515,000       
      derivative warrants exercised
    		                                    
      balance at june 30, 2021
    		                                    
      balance at march 31, 2021
    		                                    
      finance income
    		                           2,906,000 18,197,000        
      loss on financial obligation
    		                             -60,308,000     -59,583,000  
      balance at december 31, 2019
    		                           569,750  509,654,000       
      convertible debt - conversions
    		                             113,526,000       
      warrants expired
    		                                    
      dispositions
    		                                    
      balance at september 30, 2020
    		                           569,750         
      balance at june 30, 2020
    		                           569,750         
      change in fair value of biological assets realized through inventory sold
    		                             -10,685,000       
      research & development
    		                             2,410,000     196,000  
      pre-production expenses
    		                                    
      gain on currency translation of foreign operations
    		                             6,866,000  1,693,000     
      net loss from discontinued operations attributable to:
    		                                    
      net loss per common share
    		                                    
      basic and diluted
    		             -80  -120 -140         -30 -90 -377.5 -530 -3,170 -570    -1,060  
      balance at february 28, 2017
    		                             15,136,000       
      shares issued to related parties
    		                             3,000,000       
      balance at february 28, 2018
    		                             25,769,000       
      share repurchase
    		                             -827,000       
      fair value allocated to warrants
    		                             -3,108,000       
      warrants exercised
    		                             2,182,000       
      employee warrants exercised
    		                             3,980,000       
      equity component of convertible notes
    		                                    
      balance at december 31, 2018
    		                             65,133,000       
      business acquisitions
    		                             39,849,000       
      warrants reclassified from liability
    		                                    
      balance at march 31, 2020
    		                                    
      balance at june 30, 2019
    		                                    
      balance at march 31, 2019
    		                                    
      inventory obsolescence and impairment
    		                               7,715,000     
      change in fair value of contingent consideration
    		                               -761,000   -5,835,000  
      net income per common share
    		                                    
      basic and diluted
    		-50 -50    -60   -70   -10         -310  -20         -410     
      financial
    		                                    
      per share, basic and diluted
    		                                -0.403 -1.06   
      adjusted ebitda
    		                                -3,255.25 -7,897   
      balance sheet
    		                                    
      cash – unrestricted
    		                                 141,805   
      working capital
    		                                 25,841   
      biological assets
    		                                 14,539 14,539,000 12,835,000 
      property, plant and equipment
    		                                 254,097 254,097,000 152,182,000 
      operational
    		                                    
      kilogram equivalents sold
    		                                3,252 7,944   
      average gross selling price per gram
    		                                    
      branded flower
    		                                1.613 6.34   
      unbranded flower
    		                                1.12 4.03   
      average net selling price per gram
    		                                    
      average net selling price per milligram
    		                                    
      extracted oil
    		                                0.008 0.03   
      kilograms harvested
    		                                5,778.75 11,668   
      gross selling price net of excise tax.
    		                                    
      assets
    		                                    
      current assets
    		                                    
      cash and cash equivalents
    		                                  141,805,000 38,434,000 
      restricted cash
    		                                  10,350,000 104,074,000 
      accounts receivable
    		                                  22,506,000 3,709,000 
      prepaid expenses and deposits
    		                                  12,652,000 21,835,000 
      non-current assets
    		                                    
      goodwill
    		                                  103,592,000  
      liabilities
    		                                    
      current liabilities
    		                                    
      accounts payable and accrued liabilities
    		                                  61,315,000 54,722,000 
      current portion of long-term debt
    		                                  102,598,000 14,450,000 
      convertible notes
    		                                  18,685,000  
      current portion of lease obligation
    		                                  634,000 298,000 
      contingent consideration
    		                                  21,199,000 2,279,000 
      current portion of financial obligations
    		                                   3,034,000 
      non-current liabilities
    		                                    
      long-term debt
    		                                  73,783,000 123,221,000 
      lease obligation
    		                                  15,544,000 936,000 
      deferred tax liability
    		                                  2,483,000  
      financial obligation
    		                                    
      shareholders’ equity
    		                                    
      share capital
    		                                  495,993,000 111,605,000 
      warrants
    		                                  24,253,000  
      contributed surplus
    		                                  25,814,000 19,407,000 
      convertible notes - equity component
    		                                  1,884,000 3,232,000 
      accumulated deficit
    		                                  -215,350,000 -117,898,000 
      accumulated other comprehensive income
    		                                  -3,869,000  
      total shareholders’ equity
    		                                  331,004,000 18,625,000 
      total liabilities and shareholders’ equity
    		                                  632,057,000 369,217,000 
      change in fair value of investment
    		                                  165,000  
      loss before tax
    		                                  -98,003,000  
      loss on currency translation of foreign operations
    		                                  -3,869,000  
      current liability component of convertible notes
    		                                   27,394,000 
      derivative liability
    		                                   54,168,000 
      senior convertible notes
    		                                   51,342,000 
      financial obligations
    		                                   16,176,000 
      increase in fair value of biological assets
    		                                    
      gain on disposal of property, plant and equipment
    		                                    
      net loss and comprehensive loss
    		                                    
      net loss and comprehensive loss attributable to:
    		                                    
      basic and diluted loss per share
    		                                    
    Balance Sheets:
    Quarterly
    Annual
      Unit: USD2025-11-04 2025-11-03 2025-09-30 2025-07-31 2025-07-30 2025-06-30 2025-05-01 2025-04-30 2025-03-31 2025-03-18 2024-12-31 2024-11-05 2024-11-04 2024-09-30 2024-08-01 2024-06-30 2024-05-09 2024-05-08 2024-03-31 2024-03-21 2023-12-31 2023-11-13 2023-09-30 2023-08-14 2023-08-11 2023-06-30 2023-03-31 2022-12-31 2022-11-14 2022-09-30 2022-09-19 2022-08-12 2022-06-30 2022-06-14 2022-05-15 2022-03-31 2021-12-31 2021-11-11 2021-09-30 2021-08-12 2021-06-30 2021-05-11 2021-03-31 2020-12-31 2020-11-11 2020-10-13 2020-09-30 2020-08-13 2020-06-30 2020-05-15 2020-03-31 2019-12-31 2019-09-30 2019-06-30 
                                                            
        assets
      		                                                      
        current assets
      		                                                      
        cash and cash equivalents
      		240,581,000 240,581,000 240,581,000 208,224,000 208,224,000 208,224,000 220,867,000 220,867,000 220,867,000 218,359,000 218,359,000 262,976,000 262,976,000 262,976,000 182,934,000 182,934,000 188,954,000 188,954,000 188,954,000 195,041,000 195,041,000 201,983,000 201,983,000 185,455,000 185,455,000 185,455,000 213,253,000 279,586,000 291,427,000 291,427,000  362,630,000 362,630,000  422,824,000 422,824,000 558,251,000 629,142,000 629,142,000 885,418,000 885,418,000 873,445,000 873,445,000 60,376,000 21,044,000 45,337,000 21,044,000 21,629,000 21,629,000 21,157,000 21,157,000 45,337,000 141,805,000 38,434,000 
        restricted cash
      		19,798,000 19,798,000 19,798,000 19,823,000 19,823,000 19,823,000 19,792,000 19,792,000 19,792,000 19,815,000 19,815,000 20,215,000 20,215,000 20,215,000 19,972,000 19,972,000 20,122,000 20,122,000 20,122,000 19,891,000 19,891,000 19,661,000 19,661,000 19,456,000 19,456,000 19,456,000 19,380,000 19,338,000 19,336,000 19,336,000  19,406,000 19,406,000  21,947,000 21,947,000 27,013,000 33,063,000 33,063,000 52,449,000 52,449,000 100,000 100,000 5,333,000 5,330,000 15,827,000 5,330,000 5,330,000 5,330,000 5,332,000 5,332,000 15,827,000 10,350,000 104,074,000 
        marketable securities
      		139,000 139,000 139,000 37,000 37,000 37,000 139,000 139,000 139,000 139,000 139,000 483,000 483,000 483,000 156,000 156,000 170,000 170,000 170,000 225,000 225,000 265,000 265,000 3,535,000 3,535,000 3,535,000 10,992,000 21,926,000 28,794,000 28,794,000  34,224,000 34,224,000  66,491,000 66,491,000 83,724,000 119,642,000 119,642,000 97,419,000 97,419,000 33,582,000 33,582,000            
        accounts receivable
      		26,299,000 26,299,000 26,299,000 29,413,000 29,413,000 29,413,000 29,782,000 29,782,000 29,782,000 28,118,000 28,118,000 24,589,000 24,589,000 24,589,000 22,361,000 22,361,000 20,522,000 20,522,000 20,522,000 27,059,000 27,059,000 25,505,000 25,505,000 32,661,000 32,661,000 32,661,000 33,704,000 22,636,000 18,396,000 18,396,000  18,687,000 18,687,000  14,583,000 14,583,000 10,865,000 12,622,000 12,622,000 8,853,000 8,853,000 9,350,000 9,350,000 15,898,000 14,449,000 27,638,000 14,449,000 9,419,000 9,419,000 28,591,000 28,591,000 27,638,000 22,506,000 3,709,000 
        biological assets
      		3,507,000 3,507,000 3,507,000 4,085,000 4,085,000 4,085,000 3,049,000 3,049,000 3,049,000 1,187,000 1,187,000 901,000 901,000 901,000 868,000 868,000 772,000 772,000 772,000 429,000 429,000 562,000 562,000 1,330,000 1,330,000 1,330,000 1,795,000 3,477,000 2,693,000 2,693,000  2,530,000 2,530,000  3,731,000 3,731,000 4,410,000 2,880,000 2,880,000 2,341,000 2,341,000 2,835,000 2,835,000 3,531,000 4,492,000 14,309,000 4,492,000 3,047,000 3,047,000 13,808,000 13,808,000 14,309,000 14,539,000 12,835,000 
        inventory
      		125,334,000 125,334,000 125,334,000 133,466,000 133,466,000 133,466,000 132,899,000 132,899,000 132,899,000 127,919,000 127,919,000 127,863,000 127,863,000 127,863,000 132,912,000 132,912,000 134,786,000 134,786,000 134,786,000 129,060,000 129,060,000 142,550,000 142,550,000 160,407,000 160,407,000 160,407,000 153,542,000 127,782,000 144,056,000 144,056,000 95,794,000 141,622,000 141,622,000 95,794,000 140,950,000 140,950,000 29,503,000 36,093,000 36,093,000 35,194,000 35,194,000 32,837,000 32,837,000 25,613,000 31,672,000 59,942,000 31,672,000 55,633,000 55,633,000 67,588,000 67,588,000 59,942,000 28,420,000 17,485,000 
        prepaid expenses and deposits
      		12,580,000 12,580,000 12,580,000 15,478,000 15,478,000 15,478,000 10,642,000 10,642,000 10,642,000 16,860,000 16,860,000 15,507,000 15,507,000 15,507,000 19,303,000 19,303,000 15,478,000 15,478,000 15,478,000 22,464,000 22,464,000 17,814,000 17,814,000 21,792,000 21,792,000 21,792,000 21,025,000 10,110,000 12,109,000 12,109,000 4,311,000 13,929,000 13,929,000 4,311,000 12,461,000 12,461,000 4,355,000 5,358,000 5,358,000 3,202,000 3,202,000 5,097,000 5,097,000 4,622,000 7,260,000 9,564,000 7,260,000 5,212,000 5,212,000 8,578,000 8,578,000 9,564,000 12,652,000 21,835,000 
        investments
      		595,000 595,000 595,000 633,000 633,000 633,000 614,000 614,000 614,000 27,560,000 27,560,000 22,900,000 22,900,000 22,900,000 28,514,000 28,514,000 13,034,000 13,034,000 13,034,000 3,400,000 3,400,000 3,400,000 3,400,000 23,038,000 23,038,000 23,038,000 22,997,000 6,552,000 5,374,000 5,374,000  3,349,000 3,349,000  3,554,000 3,554,000 3,065,000 3,045,000 3,045,000 3,049,000 3,049,000 62,451,000 62,451,000 51,876,000           
        assets held for sale
      		746,000 746,000 746,000 758,000 758,000 758,000 251,000 251,000 251,000 19,051,000 19,051,000 19,051,000 19,051,000 19,051,000 19,051,000 19,051,000 25,233,000 25,233,000 25,233,000 6,375,000 6,375,000 8,391,000 8,391,000 8,391,000 8,391,000 8,391,000 12,563,000 6,375,000       2,998,000 2,998,000 2,998,000 2,998,000 2,998,000 2,998,000 2,998,000 2,998,000 2,998,000 2,998,000 2,998,000  2,998,000        
        net investment in subleases
      		2,754,000 2,754,000 2,754,000 2,776,000 2,776,000 2,776,000 2,719,000 2,719,000 2,719,000 2,832,000 2,832,000 2,927,000 2,927,000 2,927,000 2,819,000 2,819,000 2,818,000 2,818,000 2,818,000 2,970,000 2,970,000 3,603,000 3,603,000 3,656,000 3,656,000 3,656,000 3,650,000 3,701,000 3,844,000 3,844,000  4,099,000 4,099,000  4,137,000 4,137,000 3,991,000 3,084,000 3,084,000                
        non-current assets
      		                                                      
        long-term deposits and receivables
      		4,460,000 4,460,000 4,460,000 4,213,000 4,213,000 4,213,000 3,918,000 3,918,000 3,918,000 3,679,000 3,679,000 3,702,000 3,702,000 3,702,000 6,232,000 6,232,000 7,344,000 7,344,000 7,344,000 4,837,000 4,837,000                                  
        right of use assets
      		122,701,000 122,701,000 122,701,000 116,759,000 116,759,000 116,759,000 111,239,000 111,239,000 111,239,000 115,435,000 115,435,000 118,409,000 118,409,000 118,409,000 119,473,000 119,473,000 122,100,000 122,100,000 122,100,000 129,679,000 129,679,000 133,792,000 133,792,000 136,947,000 136,947,000 136,947,000 139,703,000 134,154,000 172,749,000 172,749,000  174,157,000 174,157,000                      
        property, plant and equipment
      		152,510,000 152,510,000 152,510,000 154,854,000 154,854,000 154,854,000 158,129,000 158,129,000 158,129,000 145,810,000 145,810,000 128,310,000 128,310,000 128,310,000 132,362,000 132,362,000 129,895,000 129,895,000 129,895,000 152,916,000 152,916,000 176,144,000 176,144,000 181,841,000 181,841,000 181,841,000 200,228,000 143,409,000 130,355,000 130,355,000  135,720,000 135,720,000  319,747,000 319,747,000 63,189,000 61,165,000 61,165,000 53,409,000 53,409,000 114,039,000 114,039,000 116,928,000 119,777,000 281,984,000 119,777,000 183,990,000 183,990,000 278,891,000 278,891,000 281,984,000 254,097,000 152,182,000 
        intangible assets
      		59,224,000 59,224,000 59,224,000 59,927,000 59,927,000 59,927,000 60,628,000 60,628,000 60,628,000 61,325,000 61,325,000 77,019,000 77,019,000 77,019,000 73,961,000 73,961,000 72,595,000 72,595,000 72,595,000 73,149,000 73,149,000 73,776,000 73,776,000 74,446,000 74,446,000 74,446,000 75,529,000 74,885,000 30,697,000 30,697,000 5,374,000 2,690,000 2,690,000 5,374,000 4,674,000 4,674,000 4,709,000 62,850,000 62,850,000 4,886,000 4,886,000 4,974,000 4,974,000 5,063,000 18,182,000 43,995,000 18,182,000 18,302,000 18,302,000 43,719,000 43,719,000 43,995,000 44,096,000 18,663,000 
        equity-accounted investees
      		391,146,000 391,146,000 391,146,000 384,152,000 384,152,000 384,152,000 407,600,000 407,600,000 407,600,000 413,124,000 413,124,000 451,068,000 451,068,000 451,068,000 571,178,000 571,178,000 560,342,000 560,342,000 560,342,000 538,331,000 538,331,000 550,523,000 550,523,000 532,818,000 532,818,000 532,818,000 535,932,000 519,255,000 526,664,000 526,664,000  480,271,000 480,271,000  466,851,000 466,851,000 412,858,000 330,279,000 330,279,000 191,599,000 191,599,000              
        goodwill
      		124,248,000 124,248,000 124,248,000 124,248,000 124,248,000 124,248,000 124,248,000 124,248,000 124,248,000 124,248,000 124,248,000 123,924,000 123,924,000 123,924,000 124,552,000 124,552,000 119,282,000 119,282,000 119,282,000 119,282,000 119,282,000 148,282,000 148,282,000 147,680,000 147,680,000 147,680,000 135,957,000 67,260,000 284,811,000 284,811,000 33,869,000 394,780,000 394,780,000 33,869,000 394,780,000 394,780,000 114,537,000 65,573,000 65,573,000       11,440,000    11,727,000 11,727,000 11,440,000 103,592,000  
        total assets
      		1,318,061,000 1,318,061,000 1,318,061,000 1,293,420,000 1,293,420,000 1,293,420,000 1,312,273,000 1,312,273,000 1,312,273,000 1,349,242,000 1,349,242,000 1,443,077,000 1,443,077,000 1,443,077,000 1,474,055,000 1,474,055,000 1,471,397,000 1,471,397,000 1,471,397,000 1,473,164,000 1,473,164,000 1,563,291,000 1,563,291,000 1,571,775,000 1,571,775,000 1,571,775,000 1,617,746,000 1,559,350,000 1,817,428,000 1,817,428,000  1,881,340,000 1,881,340,000  1,996,272,000 1,996,272,000 1,424,262,000 1,454,371,000 1,454,371,000 1,411,278,000 1,411,278,000 1,149,689,000 1,149,689,000 294,871,000 227,004,000 510,036,000 227,004,000 302,562,000 302,562,000 479,391,000 479,391,000 510,036,000 632,057,000 369,217,000 
        liabilities
      		                                                      
        current liabilities
      		                                                      
        accounts payable and accrued liabilities
      		50,652,000 50,652,000 50,652,000 49,162,000 49,162,000 49,162,000 57,887,000 57,887,000 57,887,000 56,275,000 56,275,000 54,038,000 54,038,000 54,038,000 62,389,000 62,389,000 61,360,000 61,360,000 61,360,000 68,210,000 68,210,000 57,230,000 57,230,000 62,557,000 62,557,000 62,557,000 62,106,000 48,153,000 41,861,000 41,861,000 24,955,000 37,080,000 37,080,000 24,955,000 62,123,000 62,123,000 38,452,000 28,842,000 28,842,000 24,559,000 24,559,000 22,701,000 22,701,000 23,308,000 26,388,000 58,110,000 26,388,000 36,659,000 36,659,000 73,213,000 73,213,000 58,110,000 61,315,000 54,722,000 
        lease liabilities
      		35,158,000 35,158,000 35,158,000 33,357,000 33,357,000 33,357,000 33,254,000 33,254,000 33,254,000 34,256,000 34,256,000 34,541,000 34,541,000 34,541,000 32,618,000 32,618,000 32,975,000 32,975,000 32,975,000 30,537,000 30,537,000 33,809,000 33,809,000 35,982,000 35,982,000 35,982,000 32,367,000 30,206,000   217,536,000   217,536,000                     
        derivative warrants
      		   1,000 1,000 1,000 14,000 14,000 14,000 26,000 26,000 52,000 52,000 52,000 3,900,000 3,900,000 5,700,000 5,700,000 5,700,000 4,400,000 4,400,000 6,800,000 6,800,000 3,960,000 3,960,000 3,960,000 6,200,000 11,002,000 14,902,000 14,902,000  6,402,000 6,402,000  30,058,000 30,058,000 21,700,000 29,900,000 29,900,000 54,000,000 54,000,000 73,810,000 73,810,000            
        non-current liabilities
      		                                                      
        other liabilities
      		12,989,000 12,989,000 12,989,000 5,582,000 5,582,000 5,582,000 6,227,000 6,227,000 6,227,000 7,312,000 7,312,000 7,214,000 7,214,000 7,214,000 6,236,000 6,236,000 5,918,000 5,918,000 5,918,000 4,185,000 4,185,000 6,860,000 6,860,000 5,252,000 5,252,000 5,252,000 5,088,000 2,709,000 2,495,000 2,495,000  3,010,000 3,010,000  5,087,000 5,087,000 4,505,000                  
        total liabilities
      		218,770,000 218,770,000 218,770,000 205,282,000 205,282,000 205,282,000 212,074,000 212,074,000 212,074,000 215,886,000 215,886,000 218,804,000 218,804,000 218,804,000 230,137,000 230,137,000 234,769,000 234,769,000 234,769,000 243,824,000 243,824,000 241,900,000 241,900,000 243,887,000 243,887,000 243,887,000 248,536,000 231,695,000 318,739,000 318,739,000  308,849,000 308,849,000  363,696,000 363,696,000 98,127,000 83,612,000 83,612,000 79,778,000 79,778,000 97,851,000 97,851,000 25,176,000 151,811,000 288,838,000 151,811,000 191,893,000 191,893,000 298,637,000 298,637,000 288,838,000 296,241,000 345,741,000 
        shareholders’ equity
      		                                                      
        share capital
      		2,295,625,000 2,295,625,000 2,295,625,000 2,295,254,000 2,295,254,000 2,295,254,000 2,295,107,000 2,295,107,000 2,295,107,000 2,346,728,000 2,346,728,000 2,383,233,000 2,383,233,000 2,383,233,000 2,380,753,000 2,380,753,000 2,377,163,000 2,377,163,000 2,377,163,000 2,375,950,000 2,375,950,000 2,366,775,000 2,366,775,000 2,365,845,000 2,365,845,000 2,365,845,000 2,365,319,000 2,292,810,000 2,310,918,000 2,310,918,000  2,322,273,000 2,322,273,000  2,327,443,000 2,327,443,000 2,035,704,000 2,032,007,000 2,032,007,000 2,003,013,000 2,003,013,000 1,675,595,000 1,675,595,000 762,046,000 504,671,000 509,654,000 504,671,000 471,868,000 471,868,000 510,314,000 510,314,000 509,654,000 495,993,000 111,605,000 
        warrants
      		667,000 667,000 667,000 667,000 667,000 667,000 667,000 667,000 667,000 667,000 667,000 667,000 667,000 667,000 667,000 667,000 667,000 667,000 667,000 2,260,000 2,260,000 2,260,000 2,260,000 2,260,000 2,260,000 2,260,000 2,260,000 2,260,000 2,260,000 2,260,000  8,092,000 8,092,000  8,092,000 8,092,000 8,092,000 7,735,000 7,735,000 6,138,000 6,138,000 6,138,000 6,138,000 6,138,000 25,602,000 27,831,000 25,602,000 27,831,000 27,831,000 27,831,000 27,831,000 27,831,000 24,253,000  
        contributed surplus
      		66,435,000 66,435,000 66,435,000 62,996,000 62,996,000 62,996,000 59,522,000 59,522,000 59,522,000 57,156,000 57,156,000 81,591,000 81,591,000 81,591,000 79,568,000 79,568,000 75,233,000 75,233,000 75,233,000 73,014,000 73,014,000 76,912,000 76,912,000 73,636,000 73,636,000 73,636,000 70,716,000 68,961,000 73,406,000 73,406,000  65,043,000 65,043,000  61,959,000 61,959,000 60,734,000 62,258,000 62,258,000 64,901,000 64,901,000 60,370,000 60,370,000 59,344,000 38,609,000 30,192,000 38,609,000 33,262,000 33,262,000 31,378,000 31,378,000 30,192,000 25,814,000 19,407,000 
        accumulated deficit
      		-1,312,710,000 -1,312,710,000 -1,312,710,000 -1,299,404,000 -1,299,404,000 -1,299,404,000 -1,302,289,000 -1,302,289,000 -1,302,289,000 -1,323,965,000 -1,323,965,000 -1,288,505,000 -1,288,505,000 -1,288,505,000 -1,269,177,000 -1,269,177,000 -1,263,405,000 -1,263,405,000 -1,263,405,000 -1,260,851,000 -1,260,851,000 -1,178,063,000 -1,178,063,000 -1,156,279,000 -1,156,279,000 -1,156,279,000 -1,123,759,000 -1,091,999,000 -984,042,000 -984,042,000  -896,598,000 -896,598,000  -826,414,000 -826,414,000 -788,510,000 -733,520,000 -733,520,000 -744,831,000 -744,831,000 -692,544,000 -692,544,000 -564,565,000 -500,506,000 -360,338,000 -500,506,000 -429,120,000 -429,120,000 -404,233,000 -404,233,000 -360,338,000 -215,350,000 -117,898,000 
        accumulated other comprehensive income
      		49,274,000 49,274,000 49,274,000 28,625,000 28,625,000 28,625,000 47,192,000 47,192,000 47,192,000 52,770,000 52,770,000 28,949,000 28,949,000 28,949,000 33,751,000 33,751,000 29,451,000 29,451,000 29,451,000 19,417,000 19,417,000 31,306,000 31,306,000 20,182,000 20,182,000 20,182,000 31,808,000 32,188,000 36,795,000 36,795,000  13,601,000 13,601,000  874,000 874,000 7,607,000         6,866,000    8,559,000 8,559,000 6,866,000 -3,869,000  
        total shareholders’ equity
      		1,099,291,000 1,099,291,000 1,099,291,000  1,088,138,000 1,088,138,000  1,100,199,000 1,100,199,000    1,208,214,000 1,208,214,000 1,227,841,000   1,221,388,000 1,221,388,000   1,301,469,000 1,301,469,000  1,307,923,000 1,307,923,000 1,348,623,000 1,306,499,000 1,441,616,000 1,441,616,000  1,514,690,000 1,514,690,000  1,574,233,000 1,574,233,000 1,325,906,000 1,370,759,000 1,370,759,000 1,331,500,000 1,331,500,000 1,051,838,000 1,051,838,000 265,242,000 70,655,000 216,484,000 70,655,000 106,120,000 106,120,000 176,128,000 176,128,000 216,484,000 331,004,000 18,625,000 
        total liabilities and shareholders’ equity
      		1,318,061,000 1,318,061,000 1,318,061,000  1,293,420,000 1,293,420,000  1,312,273,000 1,312,273,000    1,443,077,000 1,443,077,000 1,474,055,000   1,471,397,000 1,471,397,000   1,563,291,000 1,563,291,000  1,571,775,000 1,571,775,000 1,617,746,000 1,559,350,000 1,817,428,000 1,817,428,000  1,881,340,000 1,881,340,000  1,996,272,000 1,996,272,000 1,424,262,000 1,454,371,000 1,454,371,000 1,411,278,000 1,411,278,000 1,149,689,000 1,149,689,000 294,871,000 227,004,000 510,036,000 227,004,000 302,562,000 302,562,000 479,391,000 479,391,000 510,036,000 632,057,000 369,217,000 
        shareholders' equity
      		                                                      
        total shareholders' equity
      		   1,088,138,000   1,100,199,000   1,133,356,000 1,133,356,000 1,208,214,000    1,227,841,000 1,221,388,000   1,212,069,000 1,212,069,000   1,307,923,000                               
        total liabilities and shareholders' equity
      		   1,293,420,000   1,312,273,000   1,349,242,000 1,349,242,000 1,443,077,000    1,474,055,000 1,471,397,000   1,473,164,000 1,473,164,000   1,571,775,000                               
        contingent consideration
      		           2,279,000 2,279,000 2,279,000 2,279,000 2,279,000 2,279,000 2,279,000 2,279,000 2,279,000 2,279,000 2,279,000 2,279,000 2,279,000 2,279,000 2,279,000 2,279,000 2,279,000 2,279,000 2,279,000  2,279,000 2,279,000  2,279,000 2,279,000 2,279,000 2,279,000 2,279,000 2,279,000 2,279,000 2,279,000 2,279,000   32,501,000    35,251,000 35,251,000 32,501,000 21,199,000 2,279,000 
        non-controlling interest
      		           16,059,000 16,059,000 16,059,000 16,077,000 16,077,000 15,240,000 15,240,000 15,240,000 17,271,000 17,271,000 19,922,000 19,922,000 19,965,000 19,965,000 19,965,000 20,587,000 21,156,000 57,073,000 57,073,000  57,801,000 57,801,000  58,343,000 58,343,000 229,000       4,453,000 4,538,000 4,714,000 4,538,000 4,549,000 4,549,000 4,626,000 4,626,000 4,714,000 4,812,000 4,851,000 
        long-term deposits
      		                     9,720,000 9,720,000 9,766,000 9,766,000 9,766,000 8,618,000 8,584,000 9,041,000 9,041,000  9,068,000 9,068,000  8,988,000 8,988,000 7,725,000 7,981,000 7,981,000 7,981,000 7,981,000 7,981,000 7,981,000 2,633,000 1,800,000  1,800,000        
        current portion of lease obligations
      		                            22,565,000 22,565,000  22,989,000 22,989,000  23,975,000 23,975,000 5,701,000 4,328,000 4,328,000 415,000 415,000 416,000 416,000 409,000 405,000 722,000 405,000 236,000 236,000 608,000 608,000 722,000   
        lease obligations
      		                            236,916,000 236,916,000  239,368,000 239,368,000  242,453,000 242,453,000 27,769,000 20,205,000 20,205,000 804,000 804,000 924,000 924,000 1,031,000 1,136,000 16,227,000 1,136,000 795,000 795,000 16,561,000 16,561,000 16,227,000   
        current assets:
      		                                                      
        cash
      		                              42,808,000   42,808,000                     
        receivables
      		                              1,517,000   1,517,000                     
        income taxes recoverable
      		                              34,000   34,000                     
        deposits
      		                              1,229,000   1,229,000                     
        deferred tax assets
      		                              7,699,000   7,699,000                     
        property and equipment
      		                              86,021,000   86,021,000                     
        right-of-use assets
      		                              175,937,000   175,937,000                     
        current liabilities:
      		                                                      
        redemption obligation
      		                                                      
        current portion of lease liabilities
      		                              18,101,000   18,101,000                     
        warrant liabilities
      		                              81,000   81,000                     
        liabilities directly associated with assets held for sale
      		                                                      
        long-term debt
      		                                               64,372,000 64,372,000    73,783,000 123,221,000 
        shareholders’ equity:
      		                                                      
        equity attributable to shareholders
      		                              162,711,000   162,711,000                     
        equity attributable to non-controlling interests
      		                              31,209,000   31,209,000                     
        subsequent events
      		                                                      
        subsequent event
      		                                                      
        financial guarantee liability
      		                                     337,000 337,000                
        current portion of long-term debt
      		                                            71,063,000 177,913,000 71,063,000 8,400,000 8,400,000 169,785,000 169,785,000 177,913,000 102,598,000 14,450,000 
        derivative warrant liabilities
      		                                           428,000 4,411,000  4,411,000 10,819,000 10,819,000      
        deferred tax liability
      		                                             3,365,000    3,219,000 3,219,000 3,365,000 2,483,000  
        convertible notes
      		                                            48,408,000  48,408,000 70,612,000 70,612,000    18,685,000  
        current portion of financial obligations
      		                                                     3,034,000 
        financial obligation
      		                                                      
        convertible notes – equity component
      		                                                      
        current portion of lease obligation
      		                                                    634,000 298,000 
        lease obligation
      		                                                    15,544,000 936,000 
        convertible notes - equity component
      		                                                    1,884,000 3,232,000 
        approved by the board:
      		                                                      
        “signed” edward hellard
      		                                                      
        executive chairman & director
      		                                                      
        current liability component of convertible notes
      		                                                     27,394,000 
        derivative liability
      		                                                     54,168,000 
        senior convertible notes
      		                                                     51,342,000 
        financial obligations
      		                                                     16,176,000 
        signed edward hellard
      		                                                      
      Cashflow Statements:
      Quarterly
      Annual
        Unit: USD2025-09-30 2025-06-30 2025-05-01 2025-04-30 2025-03-31 2024-11-05 2024-09-30 2024-08-01 2024-06-30 2024-05-09 2024-05-08 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-19 2022-06-30 2022-06-14 2022-05-15 2022-03-31 2021-12-31 2021-05-11 2021-03-31 2020-12-31 2020-10-13 2020-09-30 2020-06-30 2020-05-15 2020-03-31 2019-12-31 2019-09-30 
                                         
          cash from:
        		                                 
          operating activities
        		                                 
          net loss for the period
        		  -14,707,000 -14,707,000  -19,336,000    -4,652,000 -4,652,000     -36,143,000     -38,040,000         -43,983,000   -97,491,000 
          adjustments for:
        		                                 
          income tax expense
        		     1,434,000                            
          interest and fee income
        		-357,000 1,538,000 -2,856,000 -2,856,000 -2,856,000 -5,577,000 -2,359,000 0 -3,218,000 -4,091,000 -4,091,000 -4,091,000                      
          change in fair value of biological assets
        		-120,000 447,000 -1,111,000 -1,111,000 -1,111,000 167,000 503,000 0 -336,000 -232,000 -232,000 -232,000 6,117,000 406,000 -2,122,000 3,535,000 -590,000    -3,690,000 -3,690,000 -1,733,000 94,000 94,000 -5,238,000 -30,146,000 -1,950,000 8,839,000 -7,083,000 -7,083,000 -6,004,000  
          change in fair value of inventory sold
        		                                 
          share-based compensation
        		7,964,000 1,531,000 1,388,000 1,388,000 1,388,000 5,702,000 819,000 0 4,883,000 4,843,000 4,843,000 4,843,000 10,027,000 1,480,000 1,684,000 2,209,000 7,602,000    4,204,000 4,204,000 10,438,000 3,456,000 3,456,000 5,448,000 35,580,000 1,233,000 649,000 1,236,000 1,236,000   
          depreciation and amortization
        		23,000 -238,000 14,187,000 14,187,000 14,187,000 13,970,000 -169,000 0 14,139,000 14,570,000 14,570,000 14,570,000 48,344,000 1,928,000 -3,585,000 18,259,000 36,028,000    2,439,000 2,439,000 6,176,000 2,407,000 2,407,000 8,455,000 3,169,000 181,000 -1,567,000 4,513,000 4,513,000 4,315,000 2,950,000 
          loss on disposition of assets
        		  -59,000 -59,000  35,000 -293,000 0 328,000 78,000 78,000 78,000 339,000   184,000                  
          inventory impairment and obsolescence
        		1,594,000 -352,000 591,000 591,000 591,000 413,000 -656,000 0 1,069,000 1,913,000 1,913,000 1,913,000                      
          finance costs
        		165,000 -43,000 1,690,000 1,690,000 1,690,000 1,740,000 -417,000 0 2,157,000 1,625,000 1,625,000 1,625,000 9,220,000 -316,000 -2,715,000 5,173,000 32,905,000      3,582,000 23,000 23,000    -2,618,000 2,107,000 2,107,000 2,463,000 6,960,000 
          change in estimate of fair value of derivative warrants
        		12,000 -1,000 -12,000 -12,000 -12,000 -3,848,000 -2,048,000 0 -1,800,000 1,300,000 1,300,000 1,300,000 -9,442,000 5,080,000 2,562,000 -4,802,000 -19,283,000    8,300,000 8,300,000 101,934,000 129,944,000 129,944,000         
          unrealized foreign exchange loss
        		 167,000 13,000 13,000 13,000 80,000 29,000 0 51,000 104,000 104,000 104,000    48,000     16,000 16,000 2,008,000 1,905,000  -514,000        
          transaction costs
        		         164,000 164,000 164,000                    0  
          asset impairment (recovery)
        		                                 
          share of loss (profit) of equity-accounted investees
        		  4,457,000 4,457,000 4,457,000                             
          unrealized loss on marketable securities
        		         55,000 55,000   -1,085,000  -38,635,000 60,040,000    17,834,000  40,718,000           
          additions to marketable securities
        		     -327,000               -601,000 -601,000 -112,350,000 -36,740,000 -36,740,000         
          income distributions from equity-accounted investees
        		     10,715,000           685,000    685,000 685,000            
          interest received
        		126,000 -1,653,000 2,936,000 2,936,000 2,936,000 4,496,000 1,847,000 0 2,649,000 3,172,000 3,172,000 3,172,000 10,238,000 108,000 -486,000 3,703,000 9,529,000    3,715,000 3,715,000            
          change in non-cash working capital
        		27,957,000 -13,050,000 -713,000 -713,000 -713,000 -13,000 4,637,000 0 -4,650,000 -5,059,000 -5,059,000 -5,059,000 -45,908,000 27,226,000 28,369,000 -42,562,000 -23,236,000    -14,850,000 -14,850,000 3,893,000 -7,901,000 -7,901,000 9,548,000 -26,819,000 -16,606,000 -13,956,000 15,755,000 15,755,000 -28,059,000 -4,495,000 
          net cash from operating activities
        		25,584,000 -1,671,000 7,788,000 7,788,000 7,788,000 22,794,000 18,092,000 0 4,702,000 3,301,000 3,301,000 3,301,000 -44,190,000 36,385,000 39,954,000 -48,797,000 -15,283,000    -26,020,000 -26,020,000 -99,277,000 -34,366,000 -34,366,000 -37,438,000 -92,679,000 -8,307,000 1,845,000 -13,595,000 -13,595,000 -55,881,000  
          capital expenditures
        		-3,105,000 -492,000 -1,588,000 -1,588,000 -1,588,000 -1,706,000 -516,000 0 -1,190,000 -2,410,000 -2,410,000 -2,410,000 -4,803,000 -1,795,000 147,000 -1,394,000 -8,547,000    -981,000 -981,000 -2,666,000 -119,000 -119,000 -1,948,000 -109,195,000 -959,000 5,324,000 -5,441,000 -5,441,000 -25,777,000  
          free cash flows
        		22,479,000 -2,163,000 6,200,000 6,200,000 6,200,000 21,088,000 17,576,000 0 3,512,000 891,000 891,000 891,000 -48,993,000 34,590,000 40,101,000 -50,191,000 -23,830,000    -27,001,000 -27,001,000 -101,943,000 -34,485,000 -34,485,000 -39,386,000 -201,874,000 -9,266,000 7,169,000 -19,036,000 -19,036,000 -81,658,000  
          investing activities
        		                                 
          additions to property, plant and equipment
        		-3,105,000 -492,000 -1,588,000 -1,588,000 -1,588,000 -1,706,000 -516,000 0 -1,190,000 -2,410,000 -2,410,000 -2,410,000 -4,803,000 -1,795,000 147,000 -1,394,000 -8,547,000    -981,000 -981,000 -2,666,000 -119,000 -119,000 -1,948,000 -109,195,000 -959,000 5,324,000 -5,441,000 -5,441,000 -25,777,000 -48,321,000 
          additions to intangible assets
        		     -2,421,000       -55,000 7,000 -22,000 -17,000     -56,000 -56,000    -12,000        
          additions to investments
        		            -927,000 70,000 952,000 -827,000 -14,922,000    -14,431,000 -14,431,000  -10,560,000 -10,560,000         
          principal payments from investments
        		-128,000                                 
          proceeds from disposal of investments
        		                                 
          capital refunds from equity-accounted investees
        		                                 
          capital distributions from equity-accounted investees
        		-2,592,000 2,354,000 719,000 719,000 719,000 89,758,000                            
          proceeds from disposal of property, plant and equipment
        		 -60,000 113,000 113,000 113,000   0 188,000 -62,000 -62,000 -62,000 63,000 1,095,000 -27,000 82,000                  
          acquisitions, net of cash acquired
        		       0 -1,654,000       3,695,000                  
          net cash from investing activities
        		17,683,000 -24,333,000 17,172,000 17,172,000 17,172,000 66,488,000 67,834,000 0 -1,346,000 -1,676,000 -1,676,000 -1,676,000 -23,818,000 7,964,000 -2,497,000 -6,466,000 -158,546,000    -103,972,000 -103,972,000 -282,374,000 -10,859,000 -10,859,000 -69,138,000 -211,405,000 2,675,000 6,988,000 -11,402,000 -11,402,000 -32,471,000  
          financing activities
        		                                 
          change in restricted cash
        		     -243,000 -393,000 0 150,000 -231,000 -231,000 -231,000 -348,000 -129,000 -34,000 -42,000 7,605,000    5,066,000 5,066,000 -41,066,000 5,233,000 5,233,000         
          payments on lease liabilities
        		1,865,000 -4,273,000 -7,512,000 -7,512,000 -7,512,000 -9,780,000 -74,000 0 -9,706,000 -7,516,000 -7,516,000 -7,516,000 -31,220,000 323,000 -625,000 -9,491,000                  
          repurchase of common shares
        		  -15,031,000 -15,031,000 -15,031,000                             
          proceeds from issuance of shares, net of costs
        		                         157,253,000 152,614,000     -272,000 177,019,000 
          issuance of common shares by subsidiaries
        		       0 174,000                         
          net cash from financing activities
        		1,733,000 10,853,000 -22,452,000 -22,452,000 -22,452,000 -9,240,000 136,000 0 -9,376,000 -7,712,000 -7,712,000 -7,712,000 -33,065,000 -23,000 1,078,000 -11,070,000 -33,633,000    -5,435,000 -5,435,000 1,137,818,000 860,246,000 860,246,000 121,301,000 336,822,000 4,773,000 16,761,000 -89,000 -89,000 -8,567,000  
          change in cash and cash equivalents
        		45,000,000 -15,151,000 2,508,000 2,508,000 2,508,000 80,042,000 86,062,000 0 -6,020,000 -6,087,000 -6,087,000 -6,087,000 -101,073,000 44,326,000 38,535,000 -66,333,000 -207,462,000    -135,427,000 -135,427,000 754,151,000 813,069,000 813,069,000 15,624,000 31,801,000 -1,057,000 24,652,000 -24,180,000 -24,180,000 -96,468,000  
          cash and cash equivalents, beginning of period
        		-12,643,000 2,508,000 218,359,000 218,359,000 218,359,000 182,934,000 -6,020,000 0 188,954,000 195,041,000 195,041,000 195,041,000 94,131,000 -27,798,000       558,251,000 558,251,000 -825,042,000 60,376,000 60,376,000 23,708,000  472,000      
          cash and cash equivalents, end of period
        		32,357,000 -12,643,000 220,867,000 220,867,000 220,867,000 262,976,000 80,042,000 0 182,934,000 188,954,000 188,954,000 188,954,000 -6,942,000 16,528,000 -27,798,000 213,253,000     422,824,000 422,824,000 -70,891,000 873,445,000 873,445,000 39,332,000 24,293,000 -585,000 472,000 21,157,000 21,157,000 -96,468,000 103,371,000 
          cash provided by:
        		                                 
          net income for the period
        		    -14,707,000    -4,967,000   -4,652,000          -38,040,000         -43,983,000   
          gain on disposition of assets
        		                                 
          unrealized foreign exchange (gain) loss
        		                        1,905,000         
          unrealized (gain) loss on marketable securities
        		        14,000   55,000                      
          net earnings for the period
        		                                 
          income tax recovery
        		       0 -1,284,000 -2,997,000 -2,997,000 -2,997,000     -415,000      7,787,000       -230,000 -230,000 -505,000 -512,000 
          asset (recovery) impairment
        		                                 
          share of (profit) loss of equity-accounted investees
        		     13,401,000 18,653,000      -177,000 -7,517,000 10,452,000 -9,516,000 52,178,000                 
          (gain) loss on disposition of assets
        		    -59,000                             
          asset impairment
        		  1,984,000 1,984,000 1,984,000 -258,000 -1,177,000 0 919,000 1,656,000 1,656,000 1,656,000 53,184,000 125,000 851,000 807,000 109,511,000         19,191,000 -59,838,000   5,659,000 5,659,000 0 0 
          changes to investments
        		  17,910,000 17,910,000 17,910,000 -18,952,000 -20,187,000 0 1,235,000 133,000 133,000 133,000                      
          bargain purchase gain
        		                                 
          realized loss on settlement of marketable securities
        		            92,792,000                     
          proceeds from settlement of marketable securities
        		            3,463,000 -196,000 3,411,000 26,000                  
          net cash from operating activities from continuing operations
        		     22,794,000 18,092,000 0 4,702,000 3,301,000 3,301,000 3,301,000 -48,504,000 40,552,000 35,934,000 -48,944,000       -99,277,000 -34,366,000 -34,366,000 -42,258,000 -79,740,000 -7,551,000      
          net cash from operating activities from discontinued operations
        		              4,020,000 147,000                  
          capital refunds (contributions) to equity-accounted investees
        		                                 
          distributions declared by subsidiaries
        		                                 
          unrealized gain on marketable securities
        		                     17,834,000  -4,881,000 -4,881,000         
          changes to equity-accounted investees
        		         168,000 168,000 168,000                      
          repurchase of common shares, net of costs
        		               -1,536,000                  
          net cash from investing activities from continuing operations
        		       0 -1,346,000 -1,676,000 -1,676,000 -1,676,000 -23,818,000 7,964,000 -2,497,000 -6,466,000       -282,374,000 -10,859,000 -10,859,000 -62,521,000 -183,845,000 1,004,000      
          net cash from investing activities from discontinued operations
        		                                 
          net cash from financing activities from continuing operations
        		       0 -9,376,000 -7,712,000 -7,712,000 -7,712,000 -33,065,000 -23,000 1,078,000 -11,070,000       1,137,818,000 860,246,000 860,246,000 121,940,000 337,321,000 4,012,000      
          net cash from financing activities from discontinued operations
        		                                 
          share of (profit) of equity-accounted investees
        		        -5,252,000 -9,148,000 -9,148,000 -9,148,000                      
          proceeds from common shares, net of costs
        		        -57,000                         
          effect of exchange rate changes on cash held in foreign currency
        		                      -2,016,000 -1,952,000 -1,952,000 899,000  -198,000      
          interest and fee revenue
        		            -11,072,000 -24,000 790,000 -4,211,000 -12,427,000    -3,861,000 -3,861,000            
          unrealized foreign exchange gain
        		                            628,000 -45,000 -45,000   
          exercise of cash-settled deferred share units
        		                                 
          additions to equity-accounted investees
        		              -1,897,000 -7,546,000 -111,065,000    -57,320,000 -57,320,000 -260,317,000           
          repayment of long-term debt
        		                    -10,000,000 -10,000,000            
          inventory obsolescence
        		             4,835,000 -4,886,000 9,177,000 9,319,000    1,981,000 1,981,000 13,107,000 1,754,000 1,754,000 26,016,000  9,871,000      
          loss on settlement of marketable securities
        		              5,184,000 43,804,000                  
          cash and cash equivalents, beginning of year
        		               279,586,000              45,337,000 45,337,000 0  
          loss on cancellation of contracts
        		                                 
          restructuring costs
        		                                 
          warrants issued for services
        		                                 
          other expenses
        		                       1,862,000          
          gain on disposition of marketable securities
        		                      -14,225,000 -8,019,000 -8,019,000         
          proceeds from disposal of marketable securities
        		                      24,356,000 16,058,000 16,058,000         
          acquisition, net of cash acquired
        		                    -31,149,000 -31,149,000            
          proceeds from convertible notes, net of costs
        		                         18,237,000 90,540,000     0 -678,000 
          proceeds from issuance of shares and registered offerings, net of costs
        		                      1,062,379,000 735,088,000 735,088,000         
          proceeds from exercise of derivative warrants
        		                       119,318,000 119,318,000         
          proceeds from exercise of employee warrants
        		                       151,000 151,000       126,000  
          convertible debenture settlement
        		                      0           
          payment on exercise of contingent consideration warrants
        		                                 
          cash and cash equivalents, end of year
        		                                 
          loss on disposition of pp&e
        		                       117,000          
          proceeds from disposal of pp&e
        		                      115,000 60,000 60,000 2,103,000 45,000 3,000 -2,097,000 2,100,000 2,100,000 42,000  
          payments on lease obligations
        		                    -447,000 -447,000 -643,000 -123,000 -123,000 -327,000 -199,000 7,000 277,000 -377,000 -377,000 -400,000  
          (gain) loss on disposition of pp&e
        		                        117,000         
          other incomes
        		                        1,862,000         
          cash from
        		                                 
          operating activities:
        		                                 
          net earnings for the year
        		                 31,867,000  31,867,000              
          adjustments to reconcile net earnings to net cash flows from operating activities:
        		                                 
          depreciation of property and equipment
        		                 15,203,000  15,203,000              
          depreciation of right-of-use assets
        		                 17,757,000  17,757,000              
          amortization of intangible assets
        		                 813,000  813,000              
          amortization of financing charges
        		                 86,000  86,000              
          gain on sale of discontinued operations before income tax and other adjustments
        		                 -62,453,000  -62,453,000              
          non-cash interest on convertible debentures
        		                 1,656,000  1,656,000              
          non-cash acquisition related expense
        		                 1,175,000  1,175,000              
          lease remeasurement
        		                 -3,794,000  -3,794,000              
          provision (recovery on) for impairment of intangible assets, property and equipment and right-of-use assets
        		                 5,072,000  5,072,000              
          fair value adjustments
        		                 -105,000  -105,000              
          deferred income tax
        		                 9,938,000  9,938,000              
          reclassification of accumulated translation differences from other comprehensive income
        		                                 
          equity-settled share-based payments
        		                 1,042,000  1,042,000              
          other
        		                                 
          cash from operating activities before changes in non-cash working capital
        		                 18,257,000  18,257,000              
          net change in non-cash working capital items
        		                 -11,875,000  -11,875,000              
          investing activities:
        		                                 
          purchase of property and equipment
        		                 -23,435,000  -23,435,000              
          purchase of intangible assets
        		                 -202,000  -202,000              
          proceeds on sale of liquor stores
        		                 2,157,000  2,157,000              
          net cash proceeds received on sale of discontinued operations
        		                 87,222,000  87,222,000              
          redemption obligation payment
        		                 -1,085,000  -1,085,000              
          business combination, cash acquired
        		                 406,000  406,000              
          financing activities:
        		                                 
          principal portion of lease payments
        		                 -17,879,000  -17,879,000              
          proceeds from long-term debt
        		                 21,376,000  21,376,000              
          repayments of long-term debt
        		                 -21,576,000  -21,576,000              
          redemption of convertible unsecured subordinated debentures
        		                 -77,600,000  -77,600,000              
          shares repurchased and cancelled – substantial issuer bid
        		                 -30,372,000  -30,372,000              
          shares repurchased and cancelled – normal course issuer bid
        		                 -621,000  -621,000              
          dividends paid to non-controlling interest by subsidiaries
        		                 -54,000  -54,000              
          issuance of common shares by subsidiaries, net of cash share issuance costs
        		                 37,116,000  37,116,000              
          foreign exchange loss on cash held in foreign currency
        		                                 
          increase in cash
        		                 -18,165,000  -18,165,000              
          cash and restricted cash – beginning of year
        		                 60,973,000  60,973,000              
          cash and restricted cash – end of year
        		                 42,808,000  42,808,000              
          finance (income) costs
        		                    -61,000 -61,000            
          share of profit of equity-accounted investees
        		                    -4,091,000 -4,091,000 -22,995,000           
          net loss from continuing operations for the period
        		                       -134,445,000  -134,920,000        
          items not involving cash:
        		                                 
          loss on financial obligation
        		                               0  
          acquisition
        		                      777,000           
          (repayment) proceeds of long-term debt
        		                                 
          proceeds from exercise of equity classified warrants
        		                                 
          exercise of cash-settled dsus
        		                                 
          settlement of convertible notes
        		                                 
          settlement of financial obligation
        		                               0  
          net income from continuing operations for the period
        		                        -134,445,000         
          distributions from equity-accounted investees
        		                                 
          repayment of syndicated credit agreement
        		                             -10,000,000 -10,000,000   
          exercise of warrants
        		                                 
          sales
        		                                 
          cost of sales
        		                                 
          gross margin
        		                                 
          selling and distribution expenses
        		                                 
          administrative expenses
        		                                 
          operating profit before depreciation, remeasurements and other costs
        		                                 
          impairment, lease remeasurements and other costs
        		                                 
          operating profit
        		                                 
          net income on foreign exchange from financing activities
        		                                 
          net (gain) loss on fair value adjustments
        		                                 
          income before income taxes
        		                                 
          current
        		                                 
          deferred
        		                                 
          net earnings from continuing operations
        		                                 
          net earnings from discontinued operations
        		                                 
          net earnings attributable to:
        		                                 
          equity shareholders
        		                                 
          non-controlling interest
        		                                 
          per share data attributable to equity shareholders
        		                                 
          basic earnings per share from continuing operations
        		                                 
          diluted earnings per share from continuing operations
        		                                 
          basic earnings per share
        		                                 
          diluted earnings per share
        		                                 
          cash interest paid
        		                           -1,628,000     3,688,000 
          additions to long-term investments
        		                                 
          acquisition of bridge farm
        		                               0  
          (repayment) proceeds from syndicated credit agreement, net of costs
        		                         -82,562,000        
          proceeds from term debt facility, net of costs
        		                               0 143,000 
          (repayment) proceeds from other debt instruments
        		                                 
          proceeds from exercise of derivative warrant liabilities
        		                                 
          repurchase of shares
        		                                 
          impact of foreign currency translation from discontinued operations
        		                                 
          repayment of other debt instruments
        		                                -34,089,000 
          net loss from continuing operations
        		                                 
          proceeds from syndicated credit agreement, net of costs
        		                                 
          (repayment) proceeds of credit facilities
        		                                 
          (repayment) proceeds of other debt instruments
        		                                 
          proceeds from exercise of warrants
        		                               -10,000 1,505,000 
          restricted cash
        		                             10,495,000 10,495,000 -5,477,000 93,724,000 
          impact of foreign currency translation
        		                             906,000 906,000 451,000  
          gain on disposition of pp&e
        		                                 
          proceeds from issuance of convertible notes, net of costs
        		                                 
          syndicated credit agreement costs
        		                                 
          proceeds from credit facilities
        		                                 
          gain on disposition of property, plant and equipment
        		                             -610,000 -610,000   
          inventory obsolescence and impairment
        		                             7,715,000 7,715,000   
          change in fair value of contingent consideration
        		                             1,371,000 1,371,000 12,810,000  
          proceeds from other debt instruments
        		                                 
          gain on investment
        		                                 
          goodwill impairment
        		                                 
          other acquisitions, net of cash acquired
        		                                 
          share-based payments
        		                                 
          proceeds from syndicated loan, net of costs
        		                                 
          repayment of credit facilities
        		                                 
          cash from operating activities:
        		                                 
          increase in fair value of biological assets
        		                                 
          shares issued for services
        		                                 
          share-based compensation expense
        		                                 
          loss on disposition
        		                                 
          cash from operating activities
        		                                 
          cash from investing activities:
        		                                 
          proceeds from disposal
        		                                 
          net cash used in investing activities
        		                                 
          cash from financing activities:
        		                                 
          payments to lease obligations
        		                                 
          proceeds from exercise of performance warrants
        		                                 
          net cash provided by financing activities